Surface Oncology, Inc.
Anti-CD112R compositions and methods
Last updated:
Abstract:
The invention provides anti-CD112R antibody compositions and their use in treating cancer.
Status:
Grant
Type:
Utility
Filling date:
19 Jul 2019
Issue date:
22 Mar 2022